How can we predict how aggressive a localized Prostate Cancer will be and, based on the results, decide the most appropriate treatment?

Learn about a new groundbreaking study, at this free Zoom Webinar presented on November 8th at 9:00 AM PDT (12:00 PM EDT) by Cleveland Clinic lead investigators Jane K. Nguyen, MD. PhD. and Jesse McKenney, MD. The Prostate Cancer Journal Club for Patients (PCJCP) is hosted by UroToday, the Prostate Cancer Foundation, and the University of California, San Francisco (UCSF) Patient Advocates. The paper will be discussed by Cornelia Ding, MD, and the discussion will be moderated by Matthew Cooperberg, MD, MPH from UCSF.

The study has identified microscopic features in prostate tumor tissue which can predict which patients are likely to progress to metastasis independent of Gleason grading. No patients in the study without these features progressed to metastasis. The pathology analysis was conducted on post‐prostatectomy tissue.

To register for the webinar please visit: https://ucsf.zoom.us/webinar/register/WN_1VxxFsFDQ6yVdCIc56sgYg

About the Prostate Cancer Journal Club for Patients

The PCJCP presents recent, game‐changing medical papers relevant to prostate cancer patients while avoiding medical jargon and focusing on direct impact on patients’ treatments.

The purpose is to educate patients to help them make better decisions about their prostate cancer care in collaboration with their doctors.

This will be our third PCJCP webinar. You can find recordings of our previous webinars here.